With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner. By Sheila Kaplan The…
Home »
How to Reopen Offices Safely
Flush the taps, focus on indoor air quality and consider getting creative about staff schedules. By Emily Anthes For the last 15 months, many American…
The C.D.C. urges parents to get childhood vaccinations up to date following a steep decline last year.
Pediatricians are urging U.S. parents to get their children caught up on routine vaccinations, following a decline in the number of inoculations for diseases like…
Those reports of severe Covid and deaths among the vaccinated? They’re rare, and not unexpected.
By Emily Anthes Over the last few months, a steady drumbeat of headlines has highlighted the astounding real-world effectiveness of the Covid-19 vaccines, especially the…
AstraZeneca Vaccine Carries Slightly Higher Risk of Bleeding Disorders, Study Shows
People receiving the Covid vaccine made by Oxford-AstraZeneca had a slightly increased risk of a bleeding disorder, and possibly other rare blood problems, researchers reported…
Call the Colorado COVID-19 vaccine lottery hotline
Coloradans unable to find information about their COVID-19 vaccine history in the state’s immunization database can now call a state hotline to find out if…
In the U.S., vaccines for the youngest are expected this fall.
Coronavirus vaccines may be available for U.S. children as young as six months by the fall, drugmakers say. Pfizer and Moderna are testing their vaccines…
Colorado’s falling COVID-19 hospitalizations approaching last summer peak’s, still above June 2020
COVID-19 hospitalizations have continued to fall in Colorado and are now approaching last summer’s peak, though they need to keep declining for a while to…
A U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.
On Tuesday, the United Nations is expected to adopt new targets for ending AIDS as a public health threat by 2030, seemingly a goal most…
FDA approves much-debated Alzheimer’s drug panned by experts, first in nearly 20 years
WASHINGTON — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that…